DE602004018141D1 - Polypeptide mit bindungsaffinität für her2 - Google Patents

Polypeptide mit bindungsaffinität für her2

Info

Publication number
DE602004018141D1
DE602004018141D1 DE602004018141T DE602004018141T DE602004018141D1 DE 602004018141 D1 DE602004018141 D1 DE 602004018141D1 DE 602004018141 T DE602004018141 T DE 602004018141T DE 602004018141 T DE602004018141 T DE 602004018141T DE 602004018141 D1 DE602004018141 D1 DE 602004018141D1
Authority
DE
Germany
Prior art keywords
polypeptide
her2
binding
methods
saffinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004018141T
Other languages
English (en)
Inventor
Joergen Carlsson
Stefan Stahl
Tove Eriksson
Elin Gunneriusson
Fredrik Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affibody AB
Original Assignee
Affibody AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0301987A external-priority patent/SE0301987D0/xx
Priority claimed from SE0400275A external-priority patent/SE0400275D0/xx
Application filed by Affibody AB filed Critical Affibody AB
Publication of DE602004018141D1 publication Critical patent/DE602004018141D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
DE602004018141T 2003-07-04 2004-06-30 Polypeptide mit bindungsaffinität für her2 Active DE602004018141D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0301987A SE0301987D0 (sv) 2003-07-04 2003-07-04 New polypeptide
SE0400275A SE0400275D0 (sv) 2004-02-09 2004-02-09 New polypeptide
PCT/SE2004/001049 WO2005003156A1 (en) 2003-07-04 2004-06-30 Polypeptides having binding affinity for her2

Publications (1)

Publication Number Publication Date
DE602004018141D1 true DE602004018141D1 (de) 2009-01-15

Family

ID=33566900

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018141T Active DE602004018141D1 (de) 2003-07-04 2004-06-30 Polypeptide mit bindungsaffinität für her2

Country Status (11)

Country Link
US (1) US7993650B2 (de)
EP (1) EP1641818B1 (de)
JP (2) JP4871126B2 (de)
AT (1) ATE416190T1 (de)
AU (1) AU2004253835B2 (de)
CA (1) CA2531238C (de)
DE (1) DE602004018141D1 (de)
DK (1) DK1641818T3 (de)
ES (1) ES2319426T3 (de)
HK (1) HK1092481A1 (de)
WO (1) WO2005003156A1 (de)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7993848B2 (en) 2005-03-01 2011-08-09 Affibody Ab Staphylococcus protein A domain mutants that bind to TNF-α
CN1908015B (zh) * 2005-10-18 2010-09-08 中国人民解放军军事医学科学院基础医学研究所 能抑制her2高表达肿瘤细胞增殖的稳定的小分子多肽
GB0524788D0 (en) * 2005-12-05 2006-01-11 Affibody Ab Polypeptides
US7993560B2 (en) 2006-04-20 2011-08-09 Curwood, Inc. Process for introducing an additive into a polymer melt
US8198043B2 (en) 2006-12-08 2012-06-12 General Electric Company Two helix binders
US7989216B2 (en) 2006-12-08 2011-08-02 General Electric Company Two helix binders
US7981691B2 (en) 2006-12-08 2011-07-19 General Electric Company Two helix binders
US7977118B2 (en) 2006-12-08 2011-07-12 General Electric Company Two helix binders
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
CA2733672C (en) * 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
US20110008345A1 (en) 2007-11-30 2011-01-13 Claire Ashman Antigen-binding constructs
EP2077272A1 (de) 2007-12-21 2009-07-08 Affibody AB Polypeptid-Bibliothek mit vorbestimmtem Gerüst
US9187535B2 (en) 2007-12-19 2015-11-17 Affibody Ab Polypeptide derived from protein A and able to bind PDGF
EP2072525A1 (de) * 2007-12-21 2009-06-24 Affibody AB Neue Polypeptide mit Bindungsaffinität für HER2
TW201012490A (en) 2008-05-06 2010-04-01 Glaxo Group Ltd Encapsulation of biologically active agents
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
AU2009282413B2 (en) 2008-08-11 2014-07-17 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
AR074777A1 (es) 2008-12-19 2011-02-09 Glaxo Group Ltd Proteinas de union a antigeno
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
SG162687A1 (en) * 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
CA2753332A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
WO2010097394A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Multivalent and/or multispecific rankl-binding constructs
JP2012518398A (ja) 2009-02-24 2012-08-16 グラクソ グループ リミテッド 抗原結合性構築物
EP2400990A2 (de) 2009-02-26 2012-01-04 OSI Pharmaceuticals, LLC In-situ-verfahren zur überwachung des emt-status von tumorzellen in vivo
WO2010120514A2 (en) * 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
CN102548466A (zh) 2009-07-28 2012-07-04 霍夫曼-拉罗奇有限公司 非侵入性体内光学成像方法
EP2496598B1 (de) * 2009-11-04 2017-08-02 Affibody AB Her3-bindende polypeptide
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
NZ601271A (en) 2010-01-28 2014-09-26 Glaxo Group Ltd Cd127 binding proteins
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
KR101882523B1 (ko) 2010-03-26 2018-07-26 트러스티스 오브 다트마우스 칼리지 Ｖｉｓｔａ 조절 ｔ 세포 매개 단백질, ｖｉｓｔａ 결합제 및 그것의 용도
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
CN102939538A (zh) 2010-05-07 2013-02-20 霍夫曼-拉罗奇有限公司 用于离体检测细胞的诊断方法
TW201210612A (en) 2010-06-03 2012-03-16 Glaxo Group Ltd Humanised antigen binding proteins
DE102010026061A1 (de) 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Her2/neu-Rezeptor exprimiert
KR101947356B1 (ko) 2010-11-23 2019-02-12 글락소 그룹 리미티드 온코스타틴 ｍ (ｏｓｍ)에 대한 항원 결합 단백질
CA2818621A1 (en) 2010-11-24 2012-05-31 Glaxo Group Limited Multispecific antigen binding proteins targeting hgf
EP2654915B1 (de) * 2010-12-20 2018-10-24 GE Healthcare BioProcess R&D AB Affinitätschromatographiematrix
EP3957332A1 (de) * 2010-12-22 2022-02-23 General Electric Company Radiomarkierte her2-bindende peptid-konjugate
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US9061080B2 (en) 2010-12-22 2015-06-23 Ge Healthcare Limited HER2 binding peptides labeled with aluminium-[18] fluoride complexed by NOTA
JP2014503547A (ja) * 2010-12-22 2014-02-13 ジーイー・ヘルスケア・リミテッド １８ｆを含有する有機ケイ素化合物で標識されたｈｅｒ２結合ペプチド
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
BR112013026199A2 (pt) 2011-04-15 2017-11-07 Compugen Ltd polipeptídeo isolado, proteína de fusão, sequência de ácidos nucleicos, vetor de expressão ou um vírus, célula recombinante, método de produção de um polipeptídeo com ectodomínio solúvel lsr, ou seu fragmento ou proteína de fusão, composição farmacêutica, uso de um anticorpo monoclonal ou policlonal ou um seu fragmento de ligação ao antígeno, uso do anticorpo ou do fragmento de ligação ao antígeno, uso de qualquer um de um polipeptídeo isolado, método de regulação por cima de citocinas, indução da expansão de células t, promoção da imunidade de células t específica antigênica e promoção da ativação das células t cd4+ e/ou cd8+ em um sujeito, método para potenciação de uma resposta imune secundária a um antígeno em um paciente, método de uso de pelo menos um de: um polipeptídeo isolado, método para tratamento ou prevenção de uma condição relacionada com o sistema imune, método para tratamento ou prevenção de uma doença infecciosa, método para diagnóstico de uma doença em um sujeito, método de produção de um polipeptídeo com ectodomínio solúvel tmem25, vsig10, ly6g6f, ou seu fragmento ou proteína de fusão, anticorpo monoclonal ou policlonal ou um seu fragmento de ligação ao antígeno, método de imunoterapia em um paciente e método para combinação de vacinação terapêutica com um antígeno em conjunto com a administração de qualquer um de um polipeptídeo
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
DK3415531T3 (da) 2011-05-27 2023-09-18 Glaxo Group Ltd Bcma (cd269/tnfrsf17)-bindende proteiner
SG10201604554WA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
JP2015504413A (ja) 2011-10-28 2015-02-12 パトリス リミテッド Ｐａｔ−ｌｍ１エピトープおよびそれを使用するための方法
JP6383665B2 (ja) 2012-02-13 2018-08-29 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ ＩＬ‐１β中和ヒトモノクローナル抗体
EP2831096B1 (de) * 2012-03-28 2020-04-29 GE Healthcare BioProcess R&D AB Affinitätschromatografiematrix
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
WO2014013016A1 (en) 2012-07-20 2014-01-23 Affibody Ab Method for determining the her2 status of a malignancy
CN109793893B (zh) 2012-09-07 2023-05-26 达特茅斯大学理事会 用于诊断和治疗癌症的vista调节剂
CN104768976B (zh) 2012-10-05 2020-09-22 阿菲博迪公司 Her3结合多肽
EA201500502A1 (ru) 2012-11-08 2015-10-30 Ф.Хоффманн-Ля Рош Аг Связывающие антиген her3 белки, связывающиеся с бета-шпилькой her3
WO2014076179A1 (en) 2012-11-14 2014-05-22 Affibody Ab New polypeptide
JP6146797B2 (ja) * 2013-02-15 2017-06-14 国立大学法人九州大学 Ｈｅｒ２タンパク質検出プローブ、ｈｅｒ２タンパク質検出プローブの製造方法およびｈｅｒ２タンパク質の検出方法
US9896486B2 (en) * 2013-07-10 2018-02-20 Ge Healthcare Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CA2926215A1 (en) 2013-10-06 2015-04-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modified pseudomonas exotoxin a
ES2851386T3 (es) 2013-12-18 2021-09-06 Csl Ltd Método de tratamiento de las heridas
PT3712174T (pt) 2013-12-24 2022-05-27 Janssen Pharmaceutica Nv Anticorpos e fragmentos anti-vista
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
EP3116905B1 (de) 2014-03-11 2019-01-30 Molecular Templates, Inc. Proteine mit bindungsregionen, shiga-toxin-a-untereinheiteneffektorregionen und carboxyterminierten, endoplasmatischen retikulumlokalisierungssignalmotiven
AU2015229583B2 (en) 2014-03-11 2020-07-09 Molecular Templates, Inc. Proteins comprising amino-terminal proximal Shiga toxin A Subunit effector regions and cell-targeting immunoglobulin-type binding regions
MX2016016310A (es) 2014-06-11 2017-10-20 A Green Kathy Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
US20170327600A1 (en) * 2014-07-09 2017-11-16 Kyoto University Rna-protein complex, and rna and protein delivery system using the same
CN104130315B (zh) * 2014-07-25 2017-04-05 国家纳米科学中心 一种特异靶向her2蛋白的多肽
KR101964619B1 (ko) * 2014-09-29 2019-04-02 후지필름 가부시키가이샤 항체 결합성 폴리펩타이드, 항체 결합성 융합 폴리펩타이드 및 흡착 재료
CA2962783A1 (en) 2014-10-01 2016-04-07 Medimmune, Llc Method of conjugating a polypeptide
WO2016059602A2 (en) 2014-10-16 2016-04-21 Glaxo Group Limited Methods of treating cancer and related compositions
MX2017006250A (es) 2014-11-14 2017-11-17 Hoffmann La Roche Moleculas de union a antigeno que comprenden un trimero de ligando de la familia de tnf.
CN107405398A (zh) 2014-12-05 2017-11-28 伊穆奈克斯特股份有限公司 鉴定vsig8作为推定vista受体及其用以产生vista/vsig8激动剂和拮抗剂的用途
US20180258143A1 (en) 2015-05-30 2018-09-13 Molecular Templates, Inc. De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
DK3313882T3 (da) 2015-06-24 2020-05-11 Janssen Pharmaceutica Nv Anti-VISTA antistoffer og fragmenter
EP3325510A2 (de) 2015-07-26 2018-05-30 Molecular Templates, Inc. Gegen zellen gerichtete moleküle mit effektoren der shigatoxin-a-untereinheit und cd8+-t-zellepitopen
CN105085631B (zh) * 2015-09-14 2019-01-25 国家纳米科学中心 一种特异靶向her2蛋白的多肽及其应用
CN105085632B (zh) * 2015-09-14 2019-01-25 国家纳米科学中心 一种特异靶向egfr蛋白的多肽及其应用
AR106188A1 (es) 2015-10-01 2017-12-20 Hoffmann La Roche Anticuerpos anti-cd19 humano humanizados y métodos de utilización
MX2018003630A (es) 2015-10-02 2018-08-01 F Hoffmann ­La Roche Ag Anticuerpos biespecificos para pd1 y tim3.
CA2992863A1 (en) 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Bispecific antibodies specific for a costimulatory tnf receptor
AU2016334623A1 (en) 2015-10-07 2018-02-15 F. Hoffmann-La Roche Ag Bispecific antibodies with tetravalency for a costimulatory TNF receptor
MX2018009800A (es) 2016-02-12 2018-11-09 Janssen Pharmaceutica Nv Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
GB201615588D0 (en) 2016-09-14 2016-10-26 Glaxosmithkline Ip Dev Ltd TSLP Binding Proteins
EP3231813A1 (de) 2016-03-29 2017-10-18 F. Hoffmann-La Roche AG Trimere kostimulatorische tnf-familien-ligandenhaltige antigenbindende moleküle
AU2017250294B2 (en) 2016-04-15 2022-07-21 Immunext Inc. Anti-human VISTA antibodies and use thereof
JP7285076B2 (ja) 2016-05-11 2023-06-01 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Ｔｎｆファミリーリガンドトリマーとテネイシン結合部分とを含む抗原結合分子
EP3243832A1 (de) 2016-05-13 2017-11-15 F. Hoffmann-La Roche AG Antigenbindende moleküle mit einem ligandentrimer der tnf-familie und pd1-bindungsteil
WO2018050902A2 (en) 2016-09-15 2018-03-22 Quadrucept Bio Limited Multimers, tetramers & octamers
AU2017331739A1 (en) 2016-09-23 2019-03-07 Csl Limited Coagulation factor binding proteins and uses thereof
TW201829462A (zh) 2016-11-02 2018-08-16 英商葛蘭素史克智慧財產（第二）有限公司 結合蛋白
MA47200A (fr) 2017-01-03 2019-11-13 Hoffmann La Roche Molécules bispécifiques de liaison à l'antigène comprenant un clone 20h4.9 anti-4-1bb
JP7082424B2 (ja) 2017-01-25 2022-06-08 モレキュラー テンプレーツ，インク． 脱免疫化された志賀毒素ａサブユニットエフェクター及びｃｄ８＋ｔ細胞エピトープを含む細胞標的化分子
CN110382542B (zh) 2017-03-29 2023-06-09 豪夫迈·罗氏有限公司 针对共刺激性tnf受体的双特异性抗原结合分子
WO2018178074A1 (en) 2017-03-29 2018-10-04 F. Hoffmann-La Roche Ag Trimeric antigen binding molecules specific for a costimulatory tnf receptor
EP3601345A1 (de) 2017-03-29 2020-02-05 H. Hoffnabb-La Roche Ag Bispezifische antigenbindemoleküle für einen co-stimulierenden tnf-rezeptor
UY37651A (es) * 2017-03-31 2018-10-31 Swedish Orphan Biovitrum Ab Publ Polipéptido de unión al il-1r-i
EP3606956A1 (de) 2017-04-04 2020-02-12 H. Hoffnabb-La Roche Ag Neuartige bispezifische antigenbindende moleküle zur spezifische bindung an cd40 und an fap
TWI690538B (zh) 2017-04-05 2020-04-11 瑞士商赫孚孟拉羅股份公司 特異性結合至pd1至lag3的雙特異性抗體
AR111963A1 (es) 2017-05-26 2019-09-04 Univ California Método y moléculas
EP3697812A4 (de) 2017-10-18 2021-09-22 CSL Limited Menschliche serumalbuminvarianten und ihre verwendungen
EP3703746A1 (de) 2017-11-01 2020-09-09 F. Hoffmann-La Roche AG Neuartige antigenbindende moleküle mit ligandentrimer der tnf-familie
JP7098725B2 (ja) 2017-11-01 2022-07-11 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性２＋１コントースボディ
EP3717011B1 (de) 2017-11-29 2022-12-07 CSL Limited Verfahren zur behandlung oder prävention von ischämischen reperfusionsläsionen
EP3502140A1 (de) 2017-12-21 2019-06-26 F. Hoffmann-La Roche AG Kombinationstherapie von tumorabgezielten icos-agonisten mit t-zellenbispezifischen molekülen
AR114284A1 (es) 2018-04-13 2020-08-12 Hoffmann La Roche Moléculas de unión a antígeno dirigidas a her2 que comprenden 4-1bbl
MX2019009726A (es) 2018-04-17 2020-02-05 Molecular Templates Inc Moleculas con direccion hacia her2 que comprenden andamiajes de la sub-unidad a de la toxina shiga desinmunizados.
CN112424228A (zh) 2018-07-04 2021-02-26 豪夫迈·罗氏有限公司 新型双特异性激动性4-1bb抗原结合分子
CN109182364A (zh) * 2018-08-30 2019-01-11 武汉百意欣生物技术有限公司 一种特异性识别蛋白a的多克隆抗体及其制备方法和应用
CN112654641A (zh) 2018-10-01 2021-04-13 豪夫迈·罗氏有限公司 具有与cd40的三价结合的双特异性抗原结合分子
AU2019355252A1 (en) 2018-10-01 2021-04-01 F. Hoffmann-La Roche Ag Bispecific antigen binding molecules comprising anti-FAP clone 212
BR112021012101A2 (pt) 2018-12-21 2021-09-08 F. Hoffmann-La Roche Ag Moléculas de ligação ao antígeno agonístico cd28 biespecífico, um ou mais polinucleotídeos isolados, um ou mais vetores, célula hospedeira, método de produção de uma molécula, composição farmacêutica, uso da molécula e método de inibição do crescimento de células tumorais
WO2020127628A1 (en) 2018-12-21 2020-06-25 F. Hoffmann-La Roche Ag Tumor-targeted superagonistic cd28 antigen binding molecules
GB201903767D0 (en) 2019-03-19 2019-05-01 Quadrucept Bio Ltd Multimers, tetramers & octamers
CN110128513B (zh) * 2019-03-22 2023-05-02 温州医科大学 一种对eb病毒lmp2蛋白c端胞膜外区具有结合亲和力的多肽及其应用
JP7301155B2 (ja) 2019-04-12 2023-06-30 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト リポカリンムテインを含む二重特異性抗原結合分子
WO2020260329A1 (en) 2019-06-26 2020-12-30 F. Hoffmann-La Roche Ag Fusion of an antibody binding cea and 4-1bbl
CN114531878A (zh) 2019-06-27 2022-05-24 豪夫迈·罗氏有限公司 新颖icos抗体及包含它们的肿瘤靶向抗原结合分子
CN114761030A (zh) * 2019-11-01 2022-07-15 休斯敦系统大学 具有诱导的抗肿瘤免疫的溶瘤病毒疗法
WO2021119761A1 (en) 2019-12-20 2021-06-24 Hudson Institute of Medical Research Cxcl10 binding proteins and uses thereof
WO2021190980A1 (en) 2020-03-22 2021-09-30 Quadrucept Bio Limited Multimers for viral strain evolution
AR121706A1 (es) 2020-04-01 2022-06-29 Hoffmann La Roche Moléculas de unión a antígeno biespecíficas dirigidas a ox40 y fap
CN111592584B (zh) * 2020-05-27 2021-06-29 北京市肿瘤防治研究所 Her2亲和体和诊疗核素标记物及其制备方法与应用
US20220017637A1 (en) 2020-06-23 2022-01-20 Hoffmann-La Roche Inc. Agonistic cd28 antigen binding molecules targeting her2
CN115916830A (zh) 2020-06-25 2023-04-04 豪夫迈·罗氏有限公司 抗cd3/抗cd28双特异性抗原结合分子
EP4228763A1 (de) 2020-10-16 2023-08-23 Zytox Therapeutics AB Pna-sonden für pretargeted bildgebung und therapie
EP4244254A1 (de) 2020-11-16 2023-09-20 F. Hoffmann-La Roche AG Kombinationstherapie mit fap-gerichteten cd40-agonisten
KR20230117406A (ko) 2021-01-06 2023-08-08 에프. 호프만-라 로슈 아게 Pd1-lag3 이중특이성 항체와 cd20 t 세포 이중특이성항체를 이용한 조합 요법
US20240124533A1 (en) 2021-02-15 2024-04-18 Affibody Ab New her2-binding polypeptide
WO2022184659A1 (en) 2021-03-01 2022-09-09 Quadrucept Bio Limited Antibody domains & multimers
WO2022243261A1 (en) 2021-05-19 2022-11-24 F. Hoffmann-La Roche Ag Agonistic cd40 antigen binding molecules targeting cea
AR126009A1 (es) 2021-06-02 2023-08-30 Hoffmann La Roche Moléculas agonistas de unión al antígeno cd28 que se dirigen a epcam
EP4363449A2 (de) 2021-07-02 2024-05-08 Genentech, Inc. Verfahren und zusammensetzungen zur behandlung von krebs
AR128031A1 (es) 2021-12-20 2024-03-20 Hoffmann La Roche Anticuerpos agonistas anti-ltbr y anticuerpos biespecíficos que los comprenden
WO2023186756A1 (en) 2022-03-28 2023-10-05 F. Hoffmann-La Roche Ag Interferon gamma variants and antigen binding molecules comprising these
WO2023224385A1 (ko) * 2022-05-18 2023-11-23 주식회사 케이엠디바이오 Her2-gst-sn-38 복합체 및 이를 포함하는 증식성 질환의 예방 또는 치료용 약학적 조성물
WO2024056862A1 (en) 2022-09-15 2024-03-21 Avidicure Ip B.V. Multispecific antigen binding proteins for tumor-targeting of nk cells and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (ja) 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
GB9823071D0 (en) * 1998-10-21 1998-12-16 Affibody Technology Ab A method
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
CA2373721C (en) * 1999-07-02 2013-10-15 Genentech, Inc. Compounds that bind her2
HUP0300369A2 (hu) * 2000-04-11 2003-06-28 Genentech, Inc. Többértékű antitestek és alkalmazásuk
GB0017720D0 (en) * 2000-07-19 2000-09-06 Got A Gene Ab Modified virus
EP2284181A1 (de) * 2000-10-27 2011-02-16 Novartis Vaccines and Diagnostics S.r.l. Nukleinsäure und Proteine von Gruppen Streptokokkengruppen A und B

Also Published As

Publication number Publication date
AU2004253835B2 (en) 2009-01-29
AU2004253835A1 (en) 2005-01-13
US20100048868A1 (en) 2010-02-25
WO2005003156A1 (en) 2005-01-13
JP4871126B2 (ja) 2012-02-08
ATE416190T1 (de) 2008-12-15
JP2007537700A (ja) 2007-12-27
US7993650B2 (en) 2011-08-09
EP1641818A1 (de) 2006-04-05
JP5689022B2 (ja) 2015-03-25
CA2531238C (en) 2015-02-24
ES2319426T3 (es) 2009-05-07
DK1641818T3 (da) 2009-03-16
HK1092481A1 (en) 2007-02-09
EP1641818B1 (de) 2008-12-03
JP2011229531A (ja) 2011-11-17
CA2531238A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ATE416190T1 (de) Polypeptide mit bindungsaffinität für her2
SE0400274D0 (sv) New polypeptide
UA97473C2 (ru) Выделенное антитело, которое связывается с her-3, и его применение
WO2007018619A3 (en) Chimeric therapeutic agents
HUP0500345A2 (hu) Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
DE602005016712D1 (de) Rter dna
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
BR0213303A (pt) Proteìnas de ligação de alvejamento direto
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO2005097185A3 (en) Irta-5 antibodies and their uses
WO2004024750A3 (en) Cd44-binding ligands
ATE490268T1 (de) Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
ATE522541T1 (de) Bakterielle adhäsine konformere
NO20053304L (no) NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
TNSN06085A1 (en) Nogo-a binding with enhanced affinity and pharmaceutical use thereof
SE0301987D0 (sv) New polypeptide
MX2021011330A (es) Anticuerpos de claudina-6 y conjugados de fármacos.
EP1576157A4 (de) Fluoreszenzproteine aus copepoda-speziesund verfahren zur verwendung davon
MX2022003531A (es) Polipeptidos de fusion dap10/dap12.
WO2023129995A3 (en) Chimeric antigen receptors comprising a pdz binding motif
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
MX2021010837A (es) Receptores en linfocitos t de la proteina 1 de tumor de wilms (wt1) de alta avidez.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition